Deep Medicine Acquisition Corp.
NASDAQ:DMAQ
2.96 (USD) • At close January 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2022 | 2021 | |
|---|---|---|---|
| Revenue
| 21.859 | 0 | 0 |
| Cost of Revenue
| 7.272 | 0.06 | 0.06 |
| Gross Profit
| 14.587 | -0.06 | -0.06 |
| Gross Profit Ratio
| 0.667 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 1.907 | 0.41 |
| Selling & Marketing Expenses
| 0 | 0 | 0 |
| SG&A
| 6.67 | 1.907 | 0.41 |
| Other Expenses
| 2.749 | 0.2 | 0.06 |
| Operating Expenses
| 9.419 | 2.107 | 0.41 |
| Operating Income
| -2.103 | -0.343 | -0.462 |
| Operating Income Ratio
| -0.096 | 0 | 0 |
| Total Other Income Expenses Net
| -6.692 | 1.884 | 0.048 |
| Income Before Tax
| -8.795 | -0.343 | -0.414 |
| Income Before Tax Ratio
| -0.402 | 0 | 0 |
| Income Tax Expense
| 0 | 0.058 | -0.056 |
| Net Income
| -8.795 | -0.4 | -0.358 |
| Net Income Ratio
| -0.402 | 0 | 0 |
| EPS
| -756.01 | -0.17 | -0.041 |
| EPS Diluted
| -0.76 | -0.04 | -0.041 |
| EBITDA
| -2.103 | -3.992 | -0.406 |
| EBITDA Ratio
| -0.096 | 0 | 0 |